ConductScience.org, home

Paper391007

Effects of BCG, levamisole and PS-K on the rejection of male skin grafts by female mice.

Seo S and 2 others. Agents Actions, 1979. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Effects of BCG, levamisole and PS-K on the rejection of male skin grafts by female mice. Papers, record 391007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/391007

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of BCG, levamisole and PS-K on the rejection of male skin grafts by female mice.
PubMed
Journal
Agents Actions
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.05
iCite
Revised in PubMed
2019-08-23
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Seo SS
2Yasuhara JJ
3Saeki KK

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BCG VaccineMajor topic
Graft RejectionMajor topic
LevamisoleMajor topic
PolysaccharidesMajor topic
Skin TransplantationMajor topic
Animals
Body Weight
Cell Transformation, Neoplastic
Female
Immunity, Cellular
Injections, Intraperitoneal
Injections, Subcutaneous
Male
Mice
Mice, Inbred BALB C
Mortality
Transplantation, Homologous

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1793481Double-blind levamisole trial in resectable lung cancer.Ann N Y Acad Sci1976https://conductscience.org/library/papers/793481PubMed
24795224Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.Cancer Res1973https://conductscience.org/library/papers/4795224PubMed
4319893Effect of dose, route, and schedule of BCG on antibody titer and survival of murine skin grafts across a weak histocompatibility barrier.Cancer1977https://conductscience.org/library/papers/319893PubMed
54471640Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.Cancer Res1974https://conductscience.org/library/papers/4471640PubMed
74364286BCG and cancer (first of two parts).N Engl J Med1974https://conductscience.org/library/papers/4364286PubMed
85047141Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour.Br J Cancer1972https://conductscience.org/library/papers/5047141PubMed
104686177BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.Br J Cancer1973https://conductscience.org/library/papers/4686177PubMed
1118663856Production of H-Y antibody by female mice that fail to reject male skin.Nat New Biol1972https://conductscience.org/library/papers/18663856PubMed
124377137Protein-bound polysaccharide preparation, PS-K, effective against mouse sarcoma-180 and rat ascites hepatoma AH-13 by oral use.Gan1974https://conductscience.org/library/papers/4377137PubMed
1313864477Accelerated rejection of male skin isografts by female C57BL mice infected with Bacillus Calmette-Guerin (B.C.G.).Proc Soc Exp Biol Med1962https://conductscience.org/library/papers/13864477PubMed
14793478History and prospects of immunotherapy of cancer: an introduction.Ann N Y Acad Sci1976https://conductscience.org/library/papers/793478PubMed
15782749Potentiation of T-cell mediated immunity by levamisole.Clin Exp Immunol1976https://conductscience.org/library/papers/782749PubMed
16793490Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants.Ann N Y Acad Sci1976https://conductscience.org/library/papers/793490PubMed
181183773Restoration of antibody-forming capacities by PS-K in tumor-bearing mice.Gan1975https://conductscience.org/library/papers/1183773PubMed
19345443Rejection of male skin grafts by splenectomized female mice.Science1978https://conductscience.org/library/papers/345443PubMed
21130494Effect of PS-K, a protein polysaccharide, on pulmonary metastases of a C3H mouse squamous cell carcinoma.J Natl Cancer Inst1976https://conductscience.org/library/papers/130494PubMed
22884662Immunochemotherapy of transplanted KMT-17 tumor in WKA rats by combination of cyclophosphamide and immunostimulatory protein-bound polysaccharide isolated from basidiomycetes.Cancer Res1977https://conductscience.org/library/papers/884662PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/391007

GET https://conductscience.org/api/papers/v1/391007/authors